Skip to main content
SpringerLink
Log in

Controlled temperature chain cost saving for HBV prevention

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 US dollars

References

  1. Scott N, et al. Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study. The Lancet Global Health 6: e659-e667, No. 6, Jun 2018. Available from: URL: https://doi.org/10.1016/S2214-109X(18)30219-5.

    Article  PubMed  Google Scholar 

  2. Patel MK, et al. Game changing: hepatitis B vaccine in a controlled temperature chain. The Lancet Global Health 6: e596-e597, No. 6, Jun 2018. Available from: URL: https://doi.org/10.1016/S2214-109X(18)30233-X.

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Controlled temperature chain cost saving for HBV prevention. PharmacoEcon Outcomes News 804, 10 (2018). https://doi.org/10.1007/s40274-018-4974-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4974-3

Search

Navigation